TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 75 filers reported holding TARSUS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 4.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46,582,669 | +81.4% | 2,621,422 | +84.4% | 2.72% | +88.8% |
| Q2 2023 | $25,685,096 | +143657.2% | 1,421,422 | 0.0% | 1.44% | +22.3% |
| Q1 2023 | $17,867 | -29.8% | 1,421,422 | -18.1% | 1.18% | -30.9% |
| Q4 2022 | $25,456 | -99.9% | 1,736,422 | -11.9% | 1.70% | -27.8% |
| Q3 2022 | $33,751,000 | +23.3% | 1,971,422 | +5.1% | 2.36% | +14.0% |
| Q2 2022 | $27,375,000 | +18.3% | 1,875,000 | +36.3% | 2.07% | +16.5% |
| Q1 2022 | $23,144,000 | -26.7% | 1,375,982 | -1.9% | 1.78% | -5.4% |
| Q4 2021 | $31,575,000 | +1.4% | 1,403,331 | -2.9% | 1.88% | +48.5% |
| Q3 2021 | $31,136,000 | -29.0% | 1,444,831 | -4.6% | 1.26% | -15.2% |
| Q2 2021 | $43,884,000 | -20.6% | 1,514,269 | -11.7% | 1.49% | +21.1% |
| Q1 2021 | $55,251,000 | -21.0% | 1,714,269 | 0.0% | 1.23% | -26.1% |
| Q4 2020 | $69,965,000 | – | 1,714,269 | – | 1.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,417,157 | $41,069,000 | 3.79% |
| Vivo Capital, LLC | 2,987,331 | $86,573,000 | 3.75% |
| Cormorant Asset Management, LP | 1,514,269 | $43,884,000 | 1.49% |
| Ghost Tree Capital, LLC | 170,000 | $4,927,000 | 1.35% |
| RTW INVESTMENTS, LP | 2,013,601 | $58,354,000 | 0.88% |
| COWEN AND COMPANY, LLC | 514,289 | $14,904,000 | 0.78% |
| Perceptive Advisors | 2,592,832 | $75,140,000 | 0.49% |
| Altium Capital Management LP | 70,573 | $2,045,000 | 0.47% |
| TimesSquare Capital Management, LLC | 686,705 | $19,901,000 | 0.16% |
| Jefferies Group LLC | 442,993 | $12,837,937 | 0.08% |